Related Experiment Video
Updated: Jul 29, 2025

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors
Maria J Klomp1,2, Julie Refardt1,3, Peter M van Koetsveld1
1ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, Netherlands.
Background:
Somatostatin receptor type 2 (SST2) expression is critical for the diagnosis and treatment of neuroendocrine tumors and is associated with improved patient survival. Recent data suggest that epigenetic changes such as DNA methylation and histone modifications play an important role in regulating SST2 expression and tumorigenesis of NETs. However, there are limited data on the association between epigenetic marks and SST2 expression in small intestinal neuroendocrine tumors (SI-NETs).
Methods:
Tissue samples from 16 patients diagnosed with SI-NETs and undergoing surgical resection of the primary tumor at Erasmus MC Rotterdam were analysed for SST2 expression levels and epigenetic marks surrounding the SST2 promoter region, i.e. DNA methylation and histone modifications H3K27me3 and H3K9ac. As a control, 13 normal SI-tissue samples were included.
Results:
The SI-NET samples had high SST2 protein and mRNA expression levels; a median (IQR) of 80% (70-95) SST2-positive cells and 8.2 times elevated SST2 mRNA expression level compared to normal SI-tissue (p=0.0042). In comparison to normal SI-tissue, DNA methylation levels and H3K27me3 levels were significantly lower at five out of the eight targeted CpG positions and at two out of the three examined locations within the SST2 gene promoter region of the SI-NET samples, respectively. No differences in the level of activating histone mark H3K9ac were observed between matched samples. While no correlation was found between histone modification marks and SST2 expression, SST2 mRNA expression levels correlated negatively with DNA methylation within the SST2 promoter region in both normal SI-tissue and SI-NETs (p=0.006 and p=0.04, respectively).
Conclusion:
SI-NETs have lower SST2 promoter methylation levels and lower H3K27me3 methylation levels compared to normal SI-tissue. Moreover, in contrast to the absence of a correlation with SST2 protein expression levels, significant negative correlations were found between SST2 mRNA expression level and the mean level of DNA methylation within the SST2 promoter region in both normal SI-tissue and SI-NET tissue. These results indicate that DNA methylation might be involved in regulating SST2 expression. However, the role of histone modifications in SI-NETs remains elusive.
Insights
DNA methylation in the somatostatin receptor type 2 (SST2) promoter is linked to SST2 mRNA expression in small intestinal neuroendocrine tumors (SI-NETs). Lower methylation correlates with higher SST2 expression, suggesting a regulatory role for DNA methylation.
Area of Science:
- Oncology
- Epigenetics
- Gastroenterology
Background:
- Somatostatin receptor type 2 (SST2) expression is crucial for neuroendocrine tumor (NET) diagnosis and treatment.
- Epigenetic modifications, including DNA methylation and histone modifications, are implicated in NET tumorigenesis and SST2 regulation.
- Limited data exist on the association between epigenetic marks and SST2 expression specifically in small intestinal neuroendocrine tumors (SI-NETs).
Purpose of the Study:
- To investigate the relationship between epigenetic marks (DNA methylation, H3K27me3, H3K9ac) and SST2 expression in SI-NETs.
- To compare epigenetic profiles and SST2 expression in SI-NETs versus normal small intestinal tissue.
Main Methods:
- Analysis of tissue samples from 16 SI-NET patients and 13 normal small intestinal tissue controls.
- Assessment of SST2 protein and mRNA expression levels.
- Quantification of DNA methylation and histone modifications (H3K27me3, H3K9ac) in the SST2 promoter region.
Main Results:
- SI-NET samples exhibited high SST2 protein and mRNA expression compared to normal tissue.
- SI-NETs showed significantly lower DNA methylation and H3K27me3 levels in the SST2 promoter region compared to normal tissue.
- SST2 mRNA expression negatively correlated with DNA methylation in the SST2 promoter in both SI-NETs and normal tissue.
Conclusions:
- SI-NETs are characterized by reduced DNA methylation and H3K27me3 levels at the SST2 promoter compared to normal tissue.
- DNA methylation, but not histone modifications, appears to be involved in regulating SST2 mRNA expression in SI-NETs.
- The precise role of histone modifications in SI-NETs warrants further investigation.
More Related Videos
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Epigenetic Regulation
X-chromosome...
Renewal of Intestinal Stem Cells
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

